479
Views
27
CrossRef citations to date
0
Altmetric
Original Article

A prospective study on the causes of notably raised alanine aminotransferase (ALT)

, , &
Pages 594-600 | Received 18 Oct 2015, Accepted 15 Nov 2015, Published online: 14 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Helgi Kristinn Björnsson & Einar Stefan Björnsson. (2023) Review of human risk factors for idiosyncratic drug-induced liver injury: latest advances and future goals. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-9.
Read now
Sigrún Jonsdottir, Margrét B. Arnardottir, Jóhannes A. Andresson, Helgi K. Bjornsson, Sigrun H. Lund & Einar S. Bjornsson. (2022) Prevalence, clinical characteristics and outcomes of hypoxic hepatitis in critically ill patients. Scandinavian Journal of Gastroenterology 57:3, pages 311-318.
Read now
Helgi K. Björnsson & Einar S. Björnsson. (2019) A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase. Scandinavian Journal of Gastroenterology 54:9, pages 1155-1159.
Read now
Hilmar Leonardsson, Jóhann Páll Hreinsson, Arthur Löve & Einar S. Björnsson. (2017) Hepatitis due to Epstein–Barr virus and cytomegalovirus: clinical features and outcomes. Scandinavian Journal of Gastroenterology 52:8, pages 893-897.
Read now

Articles from other publishers (23)

Rei Hirano, Tatsuo Kanda, Masayuki Honda, Shuhei Arima, Mai Totsuka, Ryota Masuzaki, Shini Kanezawa, Reina Sasaki-Tanaka, Naoki Matsumoto, Hiroaki Yamagami, Tomotaka Ishii, Masahiro Ogawa, Shuzo Nomura, Mariko Fujisawa, Kei Saito, Masaharu Takahashi, Hiroaki Okamoto & Hirofumi Kogure. (2023) Hepatitis E Virus Infection Caused Elevation of Alanine Aminotransferase Levels in a Patient with Chronic Hepatitis B and Choledocholithiasis. Reports 6:4, pages 55.
Crossref
Mouhand F. H. Mohamed, Khaled Elfert, Neha Wadhavkar, Daniel Marino, Kanhai Farrakhan, Azizullah Beran, Mohamed A. Abdallah, Abubaker Abdalla & Ronan Farrell. (2023) Choledocholithiasis Can Present with Marked Transaminases Elevation: Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 68:8, pages 3428-3435.
Crossref
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee & Victor Navarro. (2023) AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury. Hepatology 77:3, pages 1036-1065.
Crossref
晓月 谢. (2023) Etiology and Diagnosis and Treatment of Markedly Elevated Transaminases. Advances in Clinical Medicine 13:10, pages 16797-16806.
Crossref
Ji-Hee Han, Ji-Yoon Kwak, Sang-Soo Lee, Hyun-Gyu Kim, Hankyu Jeon & Ra-Ri Cha. (2022) Markedly Elevated Aspartate Aminotransferase from Non-Hepatic Causes. Journal of Clinical Medicine 12:1, pages 310.
Crossref
HK Björnsson & ES Björnsson. (2022) Drug-induced liver injury: Pathogenesis, epidemiology, clinical features, and practical management. European Journal of Internal Medicine 97, pages 26-31.
Crossref
Manasvi Gupta, Gaurav Manek, Kaitlyn Dombrowski & Rakhi Maiwall. (2021) Newer developments in viral hepatitis: Looking beyond hepatotropic viruses. World Journal of Meta-Analysis 9:6, pages 522-542.
Crossref
Temidayo Ogunmoyole, Iretiogo Dada & Oluwatosin Adebukola Adebamigbe. (2021) Ameliorative potentials of Persea americana leaf extract on toxicants - induced oxidative assault in multiple organs of wistar albino rat. Clinical Phytoscience 7:1.
Crossref
Marina Curra, Amanda F. Gabriel, Maria Beatriz C. Ferreira, Marco Antonio T. Martins, André T. Brunetto, Lauro J. Gregianin & Manoela Domingues Martins. (2021) Incidence and risk factors for oral mucositis in pediatric patients receiving chemotherapy. Supportive Care in Cancer 29:11, pages 6243-6251.
Crossref
Maomao Liu, Wen Tan, Wen Yuan, Tengke Wang, Xuran Lu & Nan Liu. (2021) Development and Validation of a Diagnostic Model to Predict the Risk of Ischemic Liver Injury After Stanford A Aortic Dissection Surgery. Frontiers in Cardiovascular Medicine 8.
Crossref
Einar S. Björnsson. (2021) Clinical management of patients with drug‐induced liver injury (DILI). United European Gastroenterology Journal 9:7, pages 781-786.
Crossref
Chalermrat Bunchorntavakul & K. Rajender Reddy. (2020) Epstein-Barr Virus and Cytomegalovirus Infections of the Liver. Gastroenterology Clinics of North America 49:2, pages 331-346.
Crossref
Danny Con, Andrew Buckle, Amanda J Nicoll & John S Lubel. (2020) Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort. JGH Open 4:2, pages 106-112.
Crossref
Kjartan B. Valgeirsson, Jóhann P. Hreinsson & Einar S. Björnsson. (2019) Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs. Liver International 39:12, pages 2341-2349.
Crossref
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey & Tom H. Karlsen. (2019) EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology 70:6, pages 1222-1261.
Crossref
Anthony C. Breu, Vilas R. Patwardhan, Jennifer Nayor, Jalpan N. Ringwala, Zachary G. Devore, Rahul B. Ganatra, Kelly E. Hathorn, Laura Horton, Sentia Iriana & Elliot B. Tapper. (2019) A Multicenter Study Into Causes of Severe Acute Liver Injury. Clinical Gastroenterology and Hepatology 17:6, pages 1201-1203.
Crossref
Alejandra Cano-Paniagua, Pedro Amariles, Nancy Angulo & Margarita Restrepo-Garay. (2019) Epidemiology of drug-induced liver injury in a University Hospital from Colombia: Updated RUCAM being used for prospective causality assessment. Annals of Hepatology 18:3, pages 501-507.
Crossref
Hemda Schmilovitz-Weiss, Rachel Gingold-Belfer, Alon Grossman, Nidal Issa, Doron Boltin, Yichayaou Beloosesky, Nira Morag Koren, Joseph Meyerovitch & Avraham Weiss. (2019) Lowering the upper limit of serum alanine aminotransferase levels may reveal significant liver disease in the elderly. PLOS ONE 14:4, pages e0212737.
Crossref
Stefanie Quickert, Philipp A. Reuken, Michael Rose, Katharina Boden & Tony Bruns. (2019) Acute Hepatitis E is an Underreported Cause of Severe Acute Liver Injury. Clinical Gastroenterology and Hepatology 17:5, pages 1004-1006.
Crossref
Mitchell R. McGill & Hartmut Jaeschke. 2019. Drug-induced Liver Injury. Drug-induced Liver Injury 221 239 .
Xiao Li, Tai-Cheng Zhou, Chang-Hui Wu, Li-Lin Tao, Rui Bi, Li-Jun Chen, De-Yao Deng, Chang Liu, Newton O. Otecko, Yang Tang, Xin Lai, Liang Zhang & Jia Wei. (2018) Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China. Scientific Reports 8:1.
Crossref
Mohammed M. Aboelsoud, Amen I. Javaid, Mazen O. Al-Qadi & James H. Lewis. (2017) Hypoxic hepatitis — its biochemical profile, causes and risk factors of mortality in critically-ill patients: A cohort study of 565 patients. Journal of Critical Care 41, pages 9-15.
Crossref
Einar Stefan Björnsson, Ottar Bergmann, Jon Gunnlaugur Jonasson, Gerdur Grondal, Björn Gudbjornsson & Sigurdur Olafsson. (2017) Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids. Clinical Gastroenterology and Hepatology 15:10, pages 1635-1636.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.